Modular Medical, Inc.(MODD)

Medical - Devices · San Diego, CA

$2.58+0.28 (+12.17%)

Delayed quote: Oct 6, 2026, 11:24 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:27:49.302Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:27:49.302Z.

Quote observation: 2026-10-06T15:24:36.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 21,029,123
Total debt · period ending 2026-06-30: 278,000
Cash · period ending 2026-06-30: 3,920,000
TTM operating EBITDA · period ending 2026-06-30: -25,531,000

FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MODD EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

MODD Competitors' EV/EBITDA Ratio

MODD

Modular Medical, Inc.

Current

Market Cap

$21.03M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LONA

LeonaBio, Inc.

vs MODD

Market Cap

$21.93M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACTU

Actuate Therapeutics Inc

vs MODD

Market Cap

$19.54M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AYTU

Aytu BioPharma, Inc.

vs MODD

Market Cap

$22.22M

EV/EBITDA Ratio

N/A

TTM Avg

6.88x

3Y Avg

5.95x

5Y Avg

5.95x

PIII

P3 Health Partners Inc.

vs MODD

Market Cap

$19.72M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ESLA

Estrella Immunopharma, Inc.

vs MODD

Market Cap

$19.20M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEUP

Neuphoria Therapeutics Inc.

vs MODD

Market Cap

$18.73M

EV/EBITDA Ratio

N/A

TTM Avg

466.09x

3Y Avg

466.09x

5Y Avg

466.09x

NXTC

NextCure, Inc.

vs MODD

Market Cap

$18.67M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KYNB

Kyntra Bio, Inc.

vs MODD

Market Cap

$24.23M

EV/EBITDA Ratio

N/A

TTM Avg

70.33x

3Y Avg

70.33x

5Y Avg

70.33x

ATOS

Atossa Therapeutics, Inc.

vs MODD

Market Cap

$24.51M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Modular Medical, Inc. (MODD)	$21.03M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$21.93M	N/A	N/A	N/A	N/A
Actuate Therapeutics Inc (ACTU)vs ›	$19.54M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.22M	N/A	6.88x	5.95x	5.95x
P3 Health Partners Inc. (PIII)vs ›	$19.72M	N/A	N/A	N/A	N/A
Estrella Immunopharma, Inc. (ESLA)vs ›	$19.20M	N/A	N/A	N/A	N/A
Neuphoria Therapeutics Inc. (NEUP)vs ›	$18.73M	N/A	466.09x	466.09x	466.09x
NextCure, Inc. (NXTC)vs ›	$18.67M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$24.23M	N/A	70.33x	70.33x	70.33x
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.51M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics